Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

10 Jul 2017 15:14

RNS Number : 6271K
Cranswick PLC
10 July 2017
 

10 July 2017

 

 

Cranswick plc (the "Company")

 

Director/PDMR Shareholding

 

The Company announces that following the vesting of share options awarded under the Cranswick plc Long Term Incentive Scheme, 4 directors and 1 PDMR exercised and subsequently sold some of these options on 7 June 2017, details of which are set out below.

 

 

Director

Number of options exercised

Number of shares sold following exercise

Average sale price per share (p)

Resultant holding

% of issued share capital

Mark Bottomley

Adam Couch

Martin Davey

Jim Brisby

Chris Aldersley

30,600

45,300

30,400

27,500

12,000

14,382

21,291

28,400

12,925

5,640

2831.79

2831.79

2831.79

2831.79

2831.79

86,142

136,755

230,869

91,949

12,930

0.1700%

0.2699%

0.4556%

0.1815%

0.0255%

 

 

 

Any queries to:

Malcolm Windeatt

Company Secretary

01482 372098

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEALXEFFAXEFF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.